| In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia, JE DeNizio, ... Nature 593 (7859), 429-434, 2021 | 593 | 2021 |
| Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment T Wang, R Narayanaswamy, H Ren, VP Torchilin Cancer biology & therapy 17 (6), 698-707, 2016 | 58 | 2016 |
| GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy LN Kasiewicz, S Biswas, A Beach, H Ren, C Dutta, AM Mazzola, E Rohde, ... Nature Communications 14 (1), 2776, 2023 | 56 | 2023 |
| Lipid nanoparticles incorporating a GalNAc ligand enable in vivo liver ANGPTL3 editing in wild-type and somatic LDLR knockout non-human primates LN Kasiewicz, S Biswas, A Beach, H Ren, C Dutta, AM Mazzola, E Rohde, ... biorxiv, 2021.11. 08.467731, 2021 | 10 | 2021 |
| Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer T Wang, R Narayanaswamy, H Ren, JW Gillespie, VA Petrenko, ... Journal of drug targeting 26 (5-6), 505-515, 2018 | 7 | 2018 |
